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leukemia is not so much the sheervolume ofinformation, but the sense that these three
streams ofthought are gradually finding certain common mechanistic ground wherein
genetics, viruses, and hormones may all play discrete parts in the pathogenesis ofthese
complex disorders. It is toward this goal that editors Gale and Golde vigorously
encourage future research directions in hope of achieving a broader understanding of
these and other cancers.
The second half of this symposium deals with more clinical issues and problems in
the treatment of leukemias. A chapter on pharmacology discusses the molecular
mechanisms of acquired malignant cell drug resistance to specific agents. It includes
Joseph Bertino's work with methotrexate resistance and the experimental antifolate
trimetrexate, as well as several clinical trials of varying drug regimens of cytosine
arabinoside for use as a CNS prophylactic. The final chapter on therapy provides an
excellent summary of the most up-to-date drug regimens, therapeutic tactics, and
prognosis in childhood and adult ALL, AML, CML, CLL, and hairy-cell leukemia.
Particular emphasis is placed on the encouraging advances made in allogeneic bone
marrow transplants and experimental work with autologous marrow treated in vitro
with monoclonal antibodies and complement. As exciting as these successes have been,
Gale appropriately reminds the reader of how limited the patient population with
histocompatible donors is and advocates using our recent fundamental advances in the
understanding ofthe basic biology ofleukemias to lead, it is hoped, to the development
of more effective and less toxic approaches to the treatment ofthese diseases.
This well-balanced symposium avoids the pitfalls to which many volumes ofthis size
succumb, by neither losing focus of the clinical issues nor attempting to address too
large a scientific field. It provides a wide representation of topics in sufficient depth to
be ofinterest to the molecular biologist as well as the student ofresearch oncology and
is more thanjust academic reading for the medical oncologist.
JAMES M. FORD
Medical Student
Yale University School ofMedicine
VIROLOGY IN MEDICINE. Edited by Henry Rothschild and J. Craig Cohen. New York,
Oxford University Press, 1985. 334 pp. $39.95.
The study of virology remains one of the frontiers of medicine. Viruses have been
implicated in a wide range of disease processes in all fields of medicine, from trivial
upper respiratory tract infections to malignancy. It is a sign ofour ignorance, however,
that a viral etiology is often postulated either as a diagnosis ofexclusion-as in cases of
gastroenteritis or upper respiratory tract infections, or as a potential cause of a poorly
understood disease-as in the case ofmultiple sclerosis or Type I diabetes.
Until recently, diagnostic methods have not been readily available, and there was
little in the way ofantiviral therapy to offer even ifa specific diagnosis could be made.
These factors further diminished interest in virology among clinicians.
All of this is changing rapidly. Viruses have been implicated in an ever-growing
number of disease processes, including AIDS. Effective and rapid assays using
immunologic techniques have been mass marketed, and new antiviral agents, such as
acyclovir, have removed viruses from the category ofuntreatable pathogens.
The book is intended as a basic reference for students and clinicians, and covers a
comprehensive range oftopics. Beginning with sections on viral structure and function,BOOK REVIEWS 463
the editors have assembled chapters which discuss the epidemiology and pathology of
viral infection, immunization, viruses and cancer, new and emerging viral diseases,
antiviral therapy, and diagnostic methods, in addition to a number of chapters which
catalogue the many viral diseases.
The book is too short to be an authoritative text on such a broad topic; therefore, it is
impossible not to mention areas where a more detailed coverage might be indicated.
For example, the section on AIDS, which is perhaps the most significant and intriguing
recently discovered disease process, merits less than a page ofdiscussion in the chapter
on new and emerging viral diseases. However, scattered shortcomings should not
detract from the generally excellentjob done by theeditors in assembling a book which
makes virology so readily accessible.
SETH A. ROSENTHAL
MedicalStudent
Yale University SchoolofMedicine
SELECTIVE NONTREATMENT OF HANDICAPPED NEWBORNS. By Robert Weir. New
York, Oxford University Press, 1984. 292 pp. $27.95.
How aggressively to treat newborns with severe birth defects is a vexing question.
Robert Weir has done a thorough and admirably dispassionate job dissecting out and
examining the critical issues entangled in this problem. The author wastes no time
pointing out that infanticide, whether active or passive, is nothing new. It was practiced
in most ancient cultures and has remained prevalent into the twentieth century. In the
U.S. today, the neonatal intensive care unit (NICU) is almost always the setting for
deciding whether anomalous newborns should be allowed to die. Here, parents and
medical teams usually have been free to choose treatment or nontreatment for these
infants with little outside interference. However, some recent cases have received
intense public scrutiny, and the federal government has taken a new interest in
applying statutes, outlawing discrimination against the handicapped to defective
infants, in order to compel medical treatment for birth defects which might be lethal if
left untreated.
At the core of this problem is the question of where the best interests of severely
anomalous infants lie: is death preferable to a seriously handicapped existence which
may be punctuated by repeated and painful corrective procedures? The range of
opinion is as wide within the medical profession as elsewhere. Since 1970 Duff and
Campbell have recognized selective nontreatment for some birth defects as reasonable,
citing severe spina bifida cystica as their prime example. On the other hand, Surgeon
General Everett Koop maintains that nontreatment in non-terminal cases is wrong; he
cites the sanctity of all human life as well as the fact that sometimes treatment is
withheld primarily to spare parents the burden of raising a handicapped child.
Somewhere in between is Norman Fost, who agrees that it is in the best interests of
some anomalous infants to be allowed to die, but who insists that the interests of
parents and society are essentially irrelevant in deciding not to treat them. He also
notes an unintended and disturbing consequence of nontreatment: some anomalous
infants survive anyway and suffer even worse handicaps because early aggressive care
was withheld.
The dispute also involves lawyers and ethicists. The author presents several major
schools of thought, with clear explanations of relevant legal and ethical principles.